← Back to headlines
Guggenheim Raises Price Target for AstraZeneca PLC
Guggenheim has increased its price target for pharmaceutical giant AstraZeneca PLC (AZN) from 15,500 GBp to 16,000 GBp, indicating a more optimistic outlook for the company's stock.
16 Mar, 18:21 — 16 Mar, 18:21
Sources
Showing 1 of 1 sources
Related Stories
Universal Studios Japan Announces Nearly $2 Billion Expansion Project
25m ago
Nvidia Reports Strong Q2 Earnings Driven by AI Demand Surge
42m ago
Nvidia Stock Rises as Bank of America Doubles Down on Bullish Forecast
47m ago
Canada Removes US Seafood from Retaliatory Tariff List Amid Trade Tensions
58m ago